A foundation responsible for reviewing applications for individually tailored medications, known as the Batthyány-Strattmann Foundation, will have its duties transferred to the National Health Insurance Authority (OEP). This change signifies a restructuring of the process for approving personalized medicine requests. The foundation currently handles the evaluation of these unique drug applications. The transfer aims to streamline the approval process and potentially integrate it more closely with national healthcare policies. Details regarding the timeline and specific implementation of the transfer have not yet been released. This move represents a significant shift in how specialized pharmaceutical requests are managed within the Hungarian healthcare system. The change was initiated following a submission by Bálint Ruff.